Subcutaneous Infliximab – the beginning of the era of biobetters in the treatment of immune-mediated inflammatory diseases
Authors:
Michnová K.
Published in the journal:
Gastroent Hepatol 2022; 76(3): 268-271
Category:
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2022 Číslo 3
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Najčítanejšie v tomto čísle
- Endoscopic therapy of gastroesophageal reflux disease using radiofrequency energy (Stretta procedure) – treatment of the first patients in the Czech Republic
- Gastroscopy – quality standards of the Czech Society of Gastroenterology
- A rare cause of biliary obstruction – a case study
- Prof. Julius Špičák, MD, PhD, jubilant